Abstract
Aim:
To have a better understanding of the expression and regulation of versican isoforms in neural precursor cells (NPC) and oligodendrogliogenesis.
Methods:
By immunocytochemistry, RT-PCR, and real-time PCR, we examined the temporal expression of versican in NPC isolated from embryonic d 16 rats as well as in oligodendrocyte (OL) lineage cells induced to differentiate from NPC, which mimicked the oligodendrogliogenesis in vivo.
Results:
We found that versican was constitutively expressed in NPC and their lineage cells, including neurons, astrocytes, and OL. In addition, 2 versican isoforms, V1/V0 and V2, were found to express at low levels in NPC, but at significantly higher levels in OL lineage cells. The peak expression of versican V2 was found at the oligo-dendrocyte precursor cell stage. Furthermore, the treatment of 2 pro-inflammatory cytokines, TNF-α and IFN-γ, enhanced the transcription of versican V2 in NPC in a dose-dependent manner, but showed no effect on V1/V0 expression.
Conclusion:
Taken together, our results demonstrate that versican, particularly the inhibitory V2 isoform, is increasingly expressed in OL lineage cells induced to differentiate from NPC. An increase in versican V2 expression after cytokine stimulation implies the interplay between the injury-induced upregulation of inflammatory cytokines and chondroitin sulfate proteoglycan-mediated inhibition of axonal regeneration after central nervous system injury.
Similar content being viewed by others
Article PDF
References
Ingber DE, Folkman J . Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 1989; 109: 317–30.
Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown AM, Iozzo RV . Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem 2003; 278: 17 491–9.
Walker HA, Whitelock JM, Garl PJ, Nemenoff RA, Stenmark KR, Weiser-Evans MC . Perlecan up-regulation of FRNK suppresses smooth muscle cell proliferation via inhibition of FAK signaling. Mol Biol Cell 2003; 14: 1941–52.
Oohira A, Matsui F, Matsuda M, Shoji R . Developmental change in the glycosaminoglycan composition of the rat brain. J Neurochem 1986; 47: 588–93.
Zimmermann DR, Ruoslahti E . Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 1989; 8: 2975–81.
Shinomura T, Nishida Y, Ito K, Kimata K . cDNA cloning of PGM, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem 1993; 268: 14 461–9.
Paulus W, Baur I, Dours-Zimmermann MT, Zimmermann DR . Differential expression of versican isoforms in brain tumors. J Neuropathol Exp Neurol 1996; 55: 528–33.
Bignami A, Perides G, Rahemtulla F . Versican, a hyaluronate-binding proteoglycan of embryonal precartilaginous mesenchyma, is mainly expressed postnatally in rat brain. J Neurosci Res 1993; 34: 97–106.
Ang LC, Zhang Y, Cao L, Yang BL, Young B, Kiani C, et al. Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J Neuropathol Exp Neurol 1999; 58: 597–605.
Wight TN . Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002; 14: 617–23.
Zhang Y, Cao L, Yang BL, Yang BB . The G3 domain of versican enhances cell proliferation via epidermal growth factor-like motifs. J Biol Chem 1998; 273: 21 342–51.
Zhang Y, Cao L, Kiani CG, Yang BL, Yang BB . The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs. J Biol Chem 1998; 273: 33 054–63.
Zhang Y, Cao L, Kiani C, Yang BL, Hu W, Yang BB . Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs. J Cell Biochem 1999; 73: 445–57.
Ito K, Shinomura T, Zako M, Ujita M, Kimata K . Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 1995; 270: 958–65.
Lemire JM, Braun KR, Maurel P, Kaplan ED, Schwartz SM, Wight TN . Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1630–9.
Aspberg A, Binkert C, Ruoslahti E . The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc Natl Acad Sci USA 1995; 92: 10 590–4.
Isogai Z, Aspberg A, Keene DR, Ono RN, Reinhardt DP, Sakai LY . Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem 2002; 277: 4565–72.
Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, Miyasaka M . Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J Biol Chem 2000; 275: 35 448–56.
Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T, Kimata K, et al. Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem 2003; 278: 41 205–12.
LeBaron RG, Zimmermann DR, Ruoslahti E . Hyaluronate binding properties of versican. J Biol Chem 1992; 267: 10 003–10.
Olin AI, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A . The proteoglycans aggrecan and versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 2001; 276: 1253–61.
Bandtlow CE, Zimmermann DR . Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000; 80: 1267–90.
Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR . Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995; 121: 2303–12.
Schmalfeldt M, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR . Versican V2 is a major extracellular matrix component of the mature bovine brain. J Biol Chem 1998; 273: 15 758–64.
Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR . Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 2000; 113: 807–16.
Wu Y, Sheng W, Chen L, Dong H, Lee V, Lu F, et al. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell 2004; 15: 2093–104.
Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW . Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 2002; 22: 2225–36.
Hu JG, Fu SL, Zhang KH, Li Y, Yin L, Lu PH, et al. Differential gene expression in neural stem cells and oligodendrocyte precursor cells: a cDNA microarray analysis. J Neurosci Res 2004; 78: 637–46.
Fu SL, Hu JG, Li Y, Yin L, Jin JQ, Xu XM, et al. Induction of rat neural stem cells into oligodendrocyte precursor cells. Acta Physiol Sin 2005; 57: 132–8.
Zhang SC, Lundberg C, Lipsitz D, O'Connor LT, Duncan ID . Generation of ligodendroglial progenitors from neural stem cells. J Neurocytol 1998; 27: 475–89.
Ben-Hur T, Ben-Menachem O, Furer V, Einstein O, Mizrachi-Kol R, Grigoriadis N . Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci 2003; 24: 623–31.
Aspberg A, Miura R, Bourdoulous S, Shimonaka M, Heinegard D, Schachner M, et al. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci USA 1997; 94: 10 116–21.
Yamaguchi Y . Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000; 57: 276–89.
Dutt S, Kleber M, Matasci M, Sommer L, Zimmermann DR . Versican V0 and V1 guide migratory neural crest cells. J Biol Chem 2006; 281: 12: 123–31.
Celio MR, Spreafico R, De BS, Vitellaro-Zuccarello L . Perineu-ronal nets: past and present. Trends Neurosci 1998; 21: 510–5.
Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L . Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002; 298: 1248–51.
Milev P, Maurel P, Chiba A, Mevissen M, Popp S, Yamaguchi Y, et al. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican. Biochem Biophys Res Commun 1998; 247: 207–12.
Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, et al. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-in-hibitory proteoglycan is NG2. J Neurosci 1999; 19: 8778–88.
Levine JM, Stincone F, Lee YS . Development and differentiation of glial precursor cells in the rat cerebellum. Glia 1993; 7: 307–21.
Giulian D, Chen J, Ingeman JE, George JK, Noponen M . The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 1989; 9: 4416–29.
Smith GM, Strunz C . Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 2005; 52: 209–18.
Boockvar JA, Schouten J, Royo N, Millard M, Spangler Z, Castelbuono D, et al. Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells. Neurosurgery 2005; 56: 163–71.
Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004; 101: 18 117–22.
Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIn-tosh TK . Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res 1996; 36: 287–91.
Hayashi M, Ueyama T, Nemoto K, Tamaki T, Senba E . Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 2000; 17: 203–18.
Nakamura M, Houghtling RA, MacArthur L, Bayer BM, Bregman BS . Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp Neurol 2003; 184: 313–25.
Yan P, Li Q, Kim GM, Xu J, Hsu CY, Xu XM . Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats. J Neurotrauma 2001; 18: 563–8.
Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH . NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 2002; 22: 2792–803.
Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636–40.
Chau CH, Shum DK, Li H, Pei J, Lui YY, Wirthlin L, et al. Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. FASEB J 2004; 18: 194–6.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by grants from the Major State Basic Research Development Program of China (973 Project, No 2003CB515302) and the Shanghai Science Development Fund (No 02JC14014).
Rights and permissions
About this article
Cite this article
Gu, Wl., Fu, Sl., Wang, Yx. et al. Expression and regulation of versican in neural precursor cells and their lineages. Acta Pharmacol Sin 28, 1519–1530 (2007). https://doi.org/10.1111/j.1745-7254.2007.00659.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00659.x
Keywords
This article is cited by
-
Chronic exposure to IL-6 induces a desensitized phenotype of the microglia
Journal of Neuroinflammation (2021)
-
Expression of a hyaluronic acid-binding proteoglycan (versican) in the cynomolgus monkey eye
International Ophthalmology (2016)
-
Effects of Olig2-Overexpressing Neural Stem Cells and Myelin Basic Protein-Activated T Cells on Recovery from Spinal Cord Injury
Neurotherapeutics (2012)
-
MicroRNA-143 expression in dorsal root ganglion neurons
Cell and Tissue Research (2011)
-
Chondroitin sulfate proteoglycans regulate the growth, differentiation and migration of multipotent neural precursor cells through the integrin signaling pathway
BMC Neuroscience (2009)